FindTrial
Sign In

Radix paeoniae rubra combined with conventional treatments for prevention of systemic inflammation reaction syndrome of patients with acute pancreatitis

Radix paeoniae rubra combined with conventional treatments for prevention of systemic inflammation reaction syndrome of patients with acute pancreatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004664
Enrollment
Unknown
Registered
2014-05-19
Start date
2014-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute pancreatitis

Interventions

Treatment group:Radix paeoniae rubra granules as an enema and be f
control:Radix paeoniae rubra granules as an enema and be f

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Patients of moderately severe acute pancreatitis;(2) Male or female;(3) Voluntary and high cooperation.

Exclusion criteria

Exclusion criteria: (1) Patients of severe acute pancreatitis(Persistent organ dysfunction > 4 8h, Marshall grade=2); (2) Pregnant and women during menstrual period; (3) Combined with serious primary diseases of heart, lung, liver, kidney and hemopoietic system etc.; (4) Patients of biliary acute pancreatitis, or complicated with acute obstructive suppurative cholangitis, and acutegangrenous cholecystitis; (5) Treatment by Chinese herbs before hospitalization; (6) Attendance in other clinical trials; (7) Low compliance.

Design outcomes

Primary

MeasureTime frame
Time of Serum amylase dropped to normal;Time of pain disappeared;Time of enteroparalysis disappeared and frequency;—

Countries

China

Contacts

Public ContactLina Wang
rena1022@163.com+86 13764524798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026